
    
      This is an open-label, multi-center, long-term treatment study conducted only in Japanese
      sites. The subjects are patients who fulfill the diagnostic criteria for bipolar I disorder,
      most recent episode depressed, as defined in the Diagnostic and Statistical Manual of Mental
      Disorders Fourth Edition, Text Revision (DSM-IV-TR) (296.50=unspecified, 296.52=moderate
      severity, 296.53=severe without psychotic features, 296.54=severe with psychotic features),
      who have completed Study HGMP (NCT#00510146) and patients who did not participate in Study
      HGMP who have been recruited to participate in Study HGMS.
    
  